JCR Pharmaceuticals Co., Ltd. (JCRRF)

JCR Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 29, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	539	394	709	1,326	2,300	4,007
Market Cap Growth	19.43%	-44.45%	-46.56%	-42.34%	-42.59%	48.47%
Enterprise Value	781	509	744	1,363	2,193	3,979
Last Close Price	4.17	4.57	6.20	10.40	17.95	33.85
PE Ratio	-	-	19.47	46.74	19.25	64.30
PS Ratio	2.25	1.78	2.50	5.13	5.47	14.73
PB Ratio	1.81	1.24	1.90	3.36	5.47	11.49
P/TBV Ratio	1.93	1.34	2.04	3.63	5.83	12.61
P/FCF Ratio	-	-	13.77	-	-	79.69
P/OCF Ratio	-	-	11.51	-	30.07	42.85
EV/Sales Ratio	3.21	2.31	2.62	5.28	5.21	14.63
EV/EBITDA Ratio	-	-	10.49	25.98	12.17	43.23
EV/EBIT Ratio	-	-	14.94	36.40	13.36	53.09
EV/FCF Ratio	-	-	14.45	-	-	79.14
Debt / Equity Ratio	1.13	0.80	0.41	0.44	0.35	0.47
Debt / EBITDA Ratio	-	-	2.17	3.27	0.83	1.78
Debt / FCF Ratio	-	-	2.99	-	-	3.26
Asset Turnover	0.34	0.32	0.44	0.36	0.60	0.50
Inventory Turnover	0.45	0.53	0.59	0.54	0.74	0.70
Quick Ratio	0.61	0.58	1.12	0.68	1.11	1.19
Current Ratio	1.16	1.16	1.91	1.34	1.48	1.67
Return on Equity (ROE)	-4.86%	-9.04%	10.17%	7.32%	32.39%	19.37%
Return on Assets (ROA)	-3.21%	-4.13%	4.78%	3.24%	14.58%	8.52%
Return on Invested Capital (ROIC)	-7.18%	-10.26%	9.36%	6.96%	43.48%	21.80%
Return on Capital Employed (ROCE)	-8.90%	-11.20%	10.40%	8.40%	36.20%	18.50%
Earnings Yield	-2.89%	-8.07%	5.14%	2.14%	5.19%	1.55%
FCF Yield	-	-26.07%	7.26%	-7.46%	-0.73%	1.26%
Dividend Yield	3.15%	2.92%	2.13%	1.45%	0.92%	0.31%
Payout Ratio	-	-	45.40%	72.61%	14.95%	15.71%
Buyback Yield / Dilution	2.06%	1.25%	-0.45%	-0.51%	-0.06%	-0.07%
Total Shareholder Return	5.21%	4.17%	1.69%	0.94%	0.86%	0.24%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.